# Senores Pharmaceuticals Ltd (SENORES)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1110.95
Day Change: +0.14%
52W High: ₹1194.4
52W Low: ₹499.15
Market Cap: ₹5,202 Cr

## Valuation
P/E: 43.9
P/B: 6.87
EPS: ₹25.73
Book Value: ₹164.41
Dividend Yield: 0%

## Returns
1Y Return: 42.64%

## Profitability
ROE: 13.79%
ROCE: 21.08%
Debt/Equity: 0.35
Revenue Growth: 68.9%
Profit Growth: 108.9%
EBITDA Margin: 31.69%
Operating Margin: 28.96%

## About
Senores Pharmaceuticals Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: Senores Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:14.481Z
Price History Updated: 2026-05-25T05:31:15.573Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:15.573Z
Quant Updated: 2026-05-25T05:31:15.573Z
Sentiment Updated: 2026-05-25T05:31:15.573Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:45.459Z
Financials Last Attempt: 2026-05-18T13:30:45.459Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2023)
Revenue: ₹14 Cr
Operating Profit: ₹2 Cr (OPM 14%)
Net Profit: ₹1 Cr
Tax: ₹1 Cr

## Annual P&L History
Mar 2023: Rev ₹14Cr | PAT ₹1Cr | OPM 14%
Mar 2024: Rev ₹35Cr | PAT ₹8Cr | OPM 36%
Mar 2025: Rev ₹215Cr | PAT ₹33Cr | OPM 19%

## Balance Sheet (Mar 2023)
Total Assets: ₹59 Cr
Total Liabilities: ₹59 Cr
Borrowings: ₹15 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Swapnil Jatinbhai Shah, MD & Director
- Deval Rajnikant Shah, Whole-Time Director & CFO
- Chetan Bipinchandra Shah, Whole-Time Director & COO
- Hanuwant Singh Shaktawat, Assistant Vice President of HR & Admin
- Vinay Kumar Mishra, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/senores
Disclaimer: For research and education only. Not investment advice.